{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:55:50Z","timestamp":1792468550026,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22 K09212"],"award-info":[{"award-number":["22 K09212"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.braindev.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T16:06:51Z","timestamp":1696003611000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cilostazol treats transient heart failure caused by ATP1A3 variant-associated polymicrogyria"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-9487","authenticated-orcid":false,"given":"Naohiro","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4931-747X","authenticated-orcid":false,"given":"Kazuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8020-9079","authenticated-orcid":false,"given":"Ayako","family":"Ohgitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2023.09.002_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2368","article-title":"De novo ATP1A3 variants cause polymicrogyria","volume":"7","author":"Miyatake","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.braindev.2023.09.002_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.braindev.2023.09.002_b0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.2358","article-title":"De novo mutations in ATP1A3 cause alternating hemiplegia of childhood","volume":"44","author":"Heinzen","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.braindev.2023.09.002_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuron.2004.06.028","article-title":"Mutations in the Na+\/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism","volume":"43","author":"de Carvalho","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.braindev.2023.09.002_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-9-15","article-title":"A novel recurrent mutation in ATP1A3 causes CAPOS syndrome","volume":"9","author":"Demos","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2023.09.002_b0030","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.braindev.2023.09.002_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/088318703322247642","article-title":"Occurrence of convulsions after administration of theophylline in a large Japanese pediatric population with asthma","volume":"16","author":"Odajima","year":"2003","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1016\/j.braindev.2023.09.002_b0040","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/0006-2952(84)90103-5","article-title":"Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography","volume":"33","author":"Umekawa","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.braindev.2023.09.002_b0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0026-895X(25)10404-5","article-title":"LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum","volume":"30","author":"Kauffman","year":"1986","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.braindev.2023.09.002_b0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5551\/jat.25577","article-title":"A randomized comparison study assessing the impact of cilostazol on the heart rate and arrhythmias by 24-hour ambulatory holter electrocardiographic monitoring after drug-eluting stent implantation for coronary artery disease","volume":"22","author":"Kwon","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.braindev.2023.09.002_b0055","first-page":"551","article-title":"Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics","volume":"10","author":"Weishaar","year":"1985","journal-title":"J Cyclic Nucleotide Protein Phosphor Res"},{"key":"10.1016\/j.braindev.2023.09.002_b0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1536\/ihj.19-116","article-title":"Cilostazol is useful for the treatment of sinus bradycardia and associated hemodynamic deterioration following heart transplantation","volume":"60","author":"Uchikawa","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.braindev.2023.09.002_b0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1054\/JCPT.2000.8696","article-title":"Effects of cilostazol on heart rate and its variation in patients with atrial fibrillation associated with bradycardia","volume":"5","author":"Toyonaga","year":"2000","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.braindev.2023.09.002_b0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/147323000403200513","article-title":"Chronotropic effect of the antithrombotic agent cilostazol in a patient with sick sinus syndrome and syncope","volume":"32","author":"Moriya","year":"2004","journal-title":"J Int Med Res"},{"key":"10.1016\/j.braindev.2023.09.002_b0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jjcc.2019.03.007","article-title":"Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: a retrospective case-control study","volume":"74","author":"Sonoura","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.braindev.2023.09.002_b0080","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1378\/chest.123.4.1161","article-title":"Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block","volume":"123","author":"Kodama-Takahashi","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.braindev.2023.09.002_b0085","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3389\/fphar.2018.01467","article-title":"Risk of heart failure hospitalization associated with cilostazol in diabetes: a nationwide case-crossover study","volume":"9","author":"Wu","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:51:47Z","timestamp":1759953107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760423001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0387760423001523"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2023.09.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol treats transient heart failure caused by ATP1A3 variant-associated polymicrogyria","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}